May 15, 2018 (Vol. 38, No. 10)


Lightning-Link® enables the direct labeling of antibodies or proteins in as little as 20 minutes, for use in R&D applications, drug discovery, and the development of diagnostic kits. Lightning-Link kits require only 30 seconds hands-on time, and there are no separation steps involved—meaning 100% of materials are retained. The company’s increased manufacturing capability means the Lightning-Link product range is now available in volumes from 10 µg to 100 mg, in single-reaction vials tested with Rabbit IgG in ELISA. For antibody manufacturers that have fixed internal processes for conjugation, bulk supply of ultra-high-quality raw materials and labels that are used in the Lightning-Link kits are also available.

Previous articleCommon Cold Blocked from Replicating by Novel Drug Molecule
Next articleNDF Identified as Critical Molecule for Facilitating Transcription through Nucleosomes